61919-885 NDC - FLUOXETINE ()

Drug Information

  • Product NDC: 61919-885
  • Proprietary Name: FLUOXETINE
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: Direct_Rx
Product Type:
FDA Application Number: ANDA078619
Marketing Category: ANDA
Start Marketing Date:8/1/2019

Package Information

No. Package Code Package Description Billing Unit
161919-885-3030 CAPSULE in 1 BOTTLE (61919-885-30)EA
261919-885-9090 CAPSULE in 1 BOTTLE (61919-885-90)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC61919-885The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAMEFLUOXETINEThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/1/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAThe translation of the route code submitted by the firm, indicating route of administration.
APPLICATION NUMBERANDA078619This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirect_RxProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025